Fluidic Devices Market

Fluidic Devices Market Outlook (2023 to 2033)

The global fluidic devices market recorded a CAGR of 7.6% in the last 10 years (2012 to 2022) and reached an industry size of US$ 225.4 million in 2022. Worldwide sales of fluidic devices are predicted to increase at a high-value CAGR of 9.4% and reach US$ 601.6 million by the end of 2033.

Fluidics is a versatile field of study that addresses a range of scientific problems, utilizing devices with microliter volumes or micrometer dimensions. These devices are fabricated using various materials, affecting flow, absorptivity, biocompatibility, and function of fluidic components.

Fluidic devices play a critical role in enabling point-of-care diagnostics by providing miniaturized, portable, and user-friendly platforms for conducting various diagnostic tests. Point-of-care diagnostics reduce turnaround time for test results by eliminating the need for samples sent to a centralized laboratory, making them accessible and efficient in resource-limited or remote settings. Microfluidic devices enable these on-site testing.

• Disease diagnostic applications amounted to a market value of US$ 120.3 million in 2022.
• Revenue from sales of fluidic devices accounted for 1.2% share of the global microfluidics market in 2022.

Integrated fluidic devices monitor health parameters, including glucose levels, cholesterol, infectious diseases, and biomarkers, enabling early detection, chronic conditions monitoring, and preventive healthcare interventions. Early intervention and timely diagnosis are crucial for improved patient outcomes, as they enable healthcare professionals to make informed treatment decisions and enhance patient care.

Fluidic devices offer versatility, portability, and efficiency, making them ideal for point-of-care diagnostics, meeting the growing demand for on-site, real-time, and patient-centered testing.

• In 2022, the National Institutes of Health (NIH) published a study showcasing the transformative impact of AI on fluidic devices used in point-of-care clinical diagnostics. This advancement has paved the way for the development of cost-effective polymer devices. An Android smartphone was used to drive an AI-controlled platform for real-time ELISA detection of the Human Cardiac Troponin I biomarker, with a detection limit of 0.98 pg/mL. This AI-powered revolution in fluidics appears to be promising.

Portable fluidic devices enable point-of-care diagnostics, providing miniaturized platforms for test results and allowing for immediate diagnosis and treatment decisions. Various research studies have reported the growing adoption of fluidic device innovation in applications for detecting and treating malignancies in the brain, lungs, heart, kidney, gut, and skin.

• According to a publication in Microfluidics and Nanofluidics 2021, researchers have been engaged in the creation of a brain-on-a-chip (BoC) system. This advanced miniaturized engineered platform is produced through a multistep lithography process and aims to assess physiological data. Development of this method holds promise for neuroscientists as it enables the investigation of axon properties, assessment of drug activity, and examination of axonal regrowth following axotomy.

Why are Fluidic Devices Widely Used in the Life Sciences Industry?

“Data Precision & Accuracy Offered by Fluidic Devices in Point-of-care Diagnostics”

Demand for precise and reliable data in life sciences, diagnostics, drug discovery, and research has grown significantly. Fluidic devices provide for exact control of fluid flow, reaction conditions, and sample manipulation, ensuring reproducibility and dependability.

Technological advancements, such as the integration of smart sensors, automation, and connectivity features, offer great potential for real-time monitoring.

• An article published in Nature Journal 2023, emphasizes the importance of fluidic technology, which transforms mobile health platforms for early patient screening by integrating optical sensing and artificial intelligence analysis.

Early detection and personalized medicine drive the medical diagnostics market, with fluidic devices meeting the increasing demand for faster and more accurate and cost-effective solutions. They can work with small quantities of samples and perform multiplexed analysis, which corresponds to the trend toward more specialized and efficient screening and diagnostic methods.

Emergence and growth of service providers in this industry have further boosted market growth. These companies are specialized in offering a wide range of services, including design, testing, manufacturing, and consulting related to fluidic technologies. By leveraging their expertise and infrastructure, microfluidic service providers enable researchers, industrial companies, and academic institutions to access and use these devices without the need for extensive in-house resources.

Such services not only address the issues associated with developing and implementing fluidic devices but also offer customized solutions tailored to the specific needs of clients, allowing them to focus on their core research or development objectives.

What are the Challenges Restricting the Adoption of Fluidic Devices?

“Lack of Interoperability between Fluidic Devices & Lab Equipment and Limited Access to Venture Capital”

Drawbacks of fluidic approaches include increased analysis time, throughput, and reliability. While these approaches offer advantages over conventional assays, they cannot meet every need. Careful consideration of existing macroscopic approaches and their inherent drawbacks is crucial for decision-making.

Lack of interoperability between microfluidic devices and existing laboratory equipment poses a significant restraint on incorporating microfluidics into established workflows and adopting them for regularized drug screening and discovery processes.

Despite successful theoretical models and studies, only a limited number of lab-on-a-chip (LOC) systems are commercialized in the market. Lack of appropriate fabrication technology, manufacturing processes, and standardized practices for producing optimized LOC devices presents a considerable challenge to their successful commercialization.

Fabrication challenges, including technical limitations and standardized processes, are hindering widespread product adoption. Standardization, improved fabrication techniques, and an understanding of fault modes are necessary to overcome these barriers.

Venture capital investment, on the other hand, is crucial for market growth. Access to venture capital is crucial for start-ups to support their early-stage development, drive innovation, attract talent, and commercialize their products. Insufficient funding limits the resources available for research and development, manufacturing capabilities, marketing efforts, and scaling operations for fluidics start-ups.

Country-wise Insights

What is the Reason Behind the Rapid Growth of the United States Market?

“Well-established and Robust Healthcare Infrastructure and Increased Investments in Microfluidic Device Production”

The United States dominated the global fluidic devices market in 2022, generating revenue that amounted to US$ 68.7 million.

• According to the Microfluidics Association (2023), venture capital investments in microfluidics in the United States are four times larger than those in Europe. This considerable disparity in financing may operate as a constraint on the worldwide market for fluidic devices. For start-ups to fund their early-stage development, promote innovation, recruit talent, and sell their products, access to venture capital is critical.

Increased investments in fluidic devices in the United States give firms a competitive edge, allowing them to pursue aggressive expansion plans and achieve a greater market presence. Microfluidics start-ups in emerging markets, on the other hand, may have difficulties in obtaining appropriate capital, restricting their potential to compete successfully on a global basis.

Which Factors Make Germany a Lucrative Market for Fluidic Device Manufacturers?

“Increasing Number of Surgical Procedures and Favorable Healthcare Policies”

Germany accounted for a market share of 4.3% in 2022.

The market in Germany is expanding with increasing outpatient research focusing on diagnostic precision in point-of-care devices under the guidance of general practitioners. This includes procedures in various medical specialties, such as cardiology, urology, and gastroenterology, which require precise fluidic devices for measurement.

Favorable healthcare policies in the nation, such as the availability of healthcare insurance and government support for medical technology, contribute to the growth of the market as well.

What are the Opportunities for Manufacturers of Fluidic Devices in China?

“Growing Demand for Point-of-care Diagnosis Driven by High Prevalence of Chronic Diseases and Increasing Healthcare Expenditure”

China accounted for 51.4% value share of the East Asia market in 2022.

Prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is on the rise in China. This has led to an increased need for point-of-care diagnosis utilizing fluidic devices for the diagnosis and treatment of these conditions, contributing to market growth.

China's healthcare industry is experiencing rapid growth, driven by factors such as an aging population, increasing healthcare expenditure, and government initiatives to improve healthcare infrastructure. This growth creates a significant demand for fluidic devices in various medical applications.

Category-wise Insights

Why are Microchip-based Fluidic Devices in High Demand Globally?

“High Throughput and Parallel Processing Capability of Microchips Driving Their Incorporation into Fluidic Devices”

The microchips segment reached a valuation of US$ 102.8 million in 2022.

Microchips offer the advantage of miniaturization, allowing for the integration of intricate fluidic channels and components within a small footprint. This enables the development of compact and highly functional fluidic devices.

Microchips enable high throughput and parallel processing of fluids. The miniaturized channels and structures on microchips allow for simultaneous analysis and processing of multiple samples, increasing efficiency and throughput.

Which Application Segment Accounts for Extensive Utilization of Fluidic Devices?

“Low Cost and Ease of Use of Fluidic Devices Driving Widespread Adoption in Disease Diagnosis”

The disease diagnostics segment dominated the global market in 2022 and is set to expand at a CAGR of 8.7% over the forecast period.

Many point-of-care diagnostic techniques are based on studying the properties of cells, and fluidic devices are used to analyze cells. Fluidic devices, in particular, are used for disease diagnostics beyond flow cytometry.

• Microfluidic and paper-based devices use tissue or blood samples to identify abnormal concentrations or cell types for clinical diagnosis. These devices are used to detect various diseases, including cancer, infectious diseases, and genetic disorders.

Which End User Makes Significant Contribution to Market Growth?

“Extensive Use of Fluidic Devices in Diagnostic Centers Due to Their Cost-effectiveness and Ability to Provide Rapid Results”

Diagnostic centers held 34% share of the market in 2022.

Diagnostic centers are increasingly adopting techniques that require precise fluidic devices for rapid, cost-effective results. This trend has contributed to the growth of the fluidic devices market in diagnostic centers.

Fluidic devices have a wide range of applications in diagnostic centers, including estimation of drug delivery, diagnostics, and research. The versatility of fluidic devices makes them applicable in various medical specialties, contributing to market growth.

Competition Landscape

The fluidic devices market is characterized by intense competition, with several key players vying for market share. Both established players and new entrants create a dynamic and competitive environment.

Key market developments are:

• In December 2022, Nutromics raised US$ 14 million for a DNA sensor platform that transmits real-time biometric data, enabling remote patient monitoring and hospital-at-home systems.
• In December 2022, Horizon Microtechnologies collaborated with Boston Micro Fabrication to develop 3D microfabrication technology, enabling micrometer-scale precision production of conductive, environmentally resistant parts. This technology helps create electrodes, electrical sensor heads, and ESD-safe components, bridging the gap between micro-AM and parts with enhanced functionality.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies producing fluidic devices, which are available in the full report.

Fluidic Devices Industry Report Scope

Key Segments of Fluidic Devices Industry Research

Product:

• Microchips
  • Polymers
  • Glass
  • Silicon
  • Ceramics
  • Others
• Flow & Pressure Sensors
• Flow & Pressure Controllers
• Microfluidic Valves
• Micropumps/Microinjectors
  • Syringe Microinjectors/Micropumps
  • Peristaltic Pumps
  • Pressure Microinjectors/Micropumps
  • Others
• Microfluidic-based-Devices
  • Organ-on-Chip
  • TEER-on-Chip
• Other Components

Application:

• Disease Diagnostics
  • Clinical Diagnostics
  • Point-of-Care Testing
• Pharma & Life Science Research & Manufacturing
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • Capillary Electrophoresis
  • Others (Micro Reactions, Microdispensing, etc.)
• Others (Forensics, Environmental, Food Safety, and Quality Control)

End User:

• Hospitals
• Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

To know more about delivery timeline for this report Contact Sales